What are the treatment options for non–small cell lung cancer (NSCLC) in patients with PD-1 ligand (PDL-1)?

Updated: Jun 05, 2020
  • Author: Winston W Tan, MD, FACP; Chief Editor: Nagla Abdel Karim, MD, PhD  more...
  • Print
Answer

PDL-1 testing results direct therapy as follows:

  • If PDL-1 expression (≥50%) is high, immunotherapy plus chemotherapy should be prescribed
  • If PDL-1 level is low, standard chemotherapy would be offered.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!